233 related articles for article (PubMed ID: 36566436)
1. In silico analysis decodes transthyretin (TTR) binding and thyroid disrupting effects of per- and polyfluoroalkyl substances (PFAS).
Dharpure R; Pramanik S; Pradhan A
Arch Toxicol; 2023 Mar; 97(3):755-768. PubMed ID: 36566436
[TBL] [Abstract][Full Text] [Related]
2. Binding interactions of perfluoroalkyl substances with thyroid hormone transport proteins and potential toxicological implications.
Ren XM; Qin WP; Cao LY; Zhang J; Yang Y; Wan B; Guo LH
Toxicology; 2016 Jul; 366-367():32-42. PubMed ID: 27528273
[TBL] [Abstract][Full Text] [Related]
3. Endocrine-disrupting activity of per- and polyfluoroalkyl substances: Exploring combined approaches of ligand and structure based modeling.
Kar S; Sepúlveda MS; Roy K; Leszczynski J
Chemosphere; 2017 Oct; 184():514-523. PubMed ID: 28622647
[TBL] [Abstract][Full Text] [Related]
4. Developing potency factors for thyroid hormone disruption by PFASs using TTR-TRβ CALUX® bioassay and assessment of PFASs mixtures in technical products.
Behnisch PA; Besselink H; Weber R; Willand W; Huang J; Brouwer A
Environ Int; 2021 Dec; 157():106791. PubMed ID: 34364217
[TBL] [Abstract][Full Text] [Related]
5. Associations between per- and polyfluoroalkyl substances exposure and thyroid hormone levels in the elderly.
Tan K; Zhang Q; Wang Y; Wang C; Hu C; Wang L; Liu H; Tian Z
Sci Total Environ; 2024 Apr; 920():170761. PubMed ID: 38340830
[TBL] [Abstract][Full Text] [Related]
6. Specific disruption of transthyretin(105-115) fibrilization using "stabilizing" inhibitors of transthyretin amyloidogenesis.
Liang Y; Ore MO; Morin S; Wilson DJ
Biochemistry; 2012 Apr; 51(16):3523-30. PubMed ID: 22482799
[TBL] [Abstract][Full Text] [Related]
7. The contribution of PFAS to thyroid hormone-displacing activity in Dutch waters: A comparison between two in vitro bioassays with chemical analysis.
de Schepper JKH; van Oorschot Y; Jaspers RJ; Hamers T; Lamoree MH; Behnisch P; Besselink H; Houtman CJ
Environ Int; 2023 Nov; 181():108256. PubMed ID: 37862862
[TBL] [Abstract][Full Text] [Related]
8. Effect-Directed Analysis Based on Transthyretin Binding Activity of Per- and Polyfluoroalkyl Substances in a Contaminated Sediment Extract.
Langberg HA; Choyke S; Hale SE; Koekkoek J; Cenijn PH; Lamoree MH; Rundberget T; Jartun M; Breedveld GD; Jenssen BM; Higgins CP; Hamers T
Environ Toxicol Chem; 2024 Feb; 43(2):245-258. PubMed ID: 37888867
[TBL] [Abstract][Full Text] [Related]
9. Thyroid Disrupting Effects of Old and New Generation PFAS.
Coperchini F; Croce L; Ricci G; Magri F; Rotondi M; Imbriani M; Chiovato L
Front Endocrinol (Lausanne); 2020; 11():612320. PubMed ID: 33542707
[TBL] [Abstract][Full Text] [Related]
10. Structure-Based Virtual Screening Protocol for in Silico Identification of Potential Thyroid Disrupting Chemicals Targeting Transthyretin.
Zhang J; Begum A; Brännström K; Grundström C; Iakovleva I; Olofsson A; Sauer-Eriksson AE; Andersson PL
Environ Sci Technol; 2016 Nov; 50(21):11984-11993. PubMed ID: 27668830
[TBL] [Abstract][Full Text] [Related]
11. Hydroxylated polychlorinated biphenyls selectively bind transthyretin in blood and inhibit amyloidogenesis: rationalizing rodent PCB toxicity.
Purkey HE; Palaninathan SK; Kent KC; Smith C; Safe SH; Sacchettini JC; Kelly JW
Chem Biol; 2004 Dec; 11(12):1719-28. PubMed ID: 15610856
[TBL] [Abstract][Full Text] [Related]
12. A substructure combination strategy to create potent and selective transthyretin kinetic stabilizers that prevent amyloidogenesis and cytotoxicity.
Choi S; Reixach N; Connelly S; Johnson SM; Wilson IA; Kelly JW
J Am Chem Soc; 2010 Feb; 132(4):1359-70. PubMed ID: 20043671
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and characterization of potent bivalent amyloidosis inhibitors that bind prior to transthyretin tetramerization.
Green NS; Palaninathan SK; Sacchettini JC; Kelly JW
J Am Chem Soc; 2003 Nov; 125(44):13404-14. PubMed ID: 14583036
[TBL] [Abstract][Full Text] [Related]
14. Linking Transthyretin-Binding Chemicals and Free Thyroid Hormones: In Vitro to In Vivo Extrapolation Based on a Competitive Binding Model.
Huang K; Zhou W; Fu J; Zhang Q; Teng Y; Gu L; Fu Y; Hu B; Mei Y; Zhang H; Zhang A; Fu J; Jiang G
Environ Sci Technol; 2023 Jun; 57(25):9130-9139. PubMed ID: 37261382
[TBL] [Abstract][Full Text] [Related]
15. Binding of common organic UV-filters to the thyroid hormone transport protein transthyretin using in vitro and in silico studies: Potential implications in health.
Cotrina EY; Oliveira Â; Llop J; Quintana J; Biarnés X; Cardoso I; Díaz-Cruz MS; Arsequell G
Environ Res; 2023 Jan; 217():114836. PubMed ID: 36400222
[TBL] [Abstract][Full Text] [Related]
16. Chromium(III) ion and thyroxine cooperate to stabilize the transthyretin tetramer and suppress in vitro amyloid fibril formation.
Sato T; Ando Y; Susuki S; Mikami F; Ikemizu S; Nakamura M; Suhr O; Anraku M; Kai T; Suico MA; Shuto T; Mizuguchi M; Yamagata Y; Kai H
FEBS Lett; 2006 Jan; 580(2):491-6. PubMed ID: 16386248
[TBL] [Abstract][Full Text] [Related]
17. Genistein, a natural product from soy, is a potent inhibitor of transthyretin amyloidosis.
Green NS; Foss TR; Kelly JW
Proc Natl Acad Sci U S A; 2005 Oct; 102(41):14545-50. PubMed ID: 16195386
[TBL] [Abstract][Full Text] [Related]
18. In vitro human cell-based TTR-TRβ CALUX assay indicates thyroid hormone transport disruption of short-chain, medium-chain, and long-chain chlorinated paraffins.
Sprengel J; Behnisch PA; Besselink H; Brouwer A; Vetter W
Arch Toxicol; 2021 Apr; 95(4):1391-1396. PubMed ID: 33555371
[TBL] [Abstract][Full Text] [Related]
19. The crystal structure of transthyretin in complex with diethylstilbestrol: a promising template for the design of amyloid inhibitors.
Morais-de-Sá E; Pereira PJ; Saraiva MJ; Damas AM
J Biol Chem; 2004 Dec; 279(51):53483-90. PubMed ID: 15469931
[TBL] [Abstract][Full Text] [Related]
20. Novel transthyretin amyloid fibril formation inhibitors: synthesis, biological evaluation, and X-ray structural analysis.
Palaninathan SK; Mohamedmohaideen NN; Orlandini E; Ortore G; Nencetti S; Lapucci A; Rossello A; Freundlich JS; Sacchettini JC
PLoS One; 2009 Jul; 4(7):e6290. PubMed ID: 19621084
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
